|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||243.310 g·mol−1|
|3D model (JSmol)|
YM-348 is an indazole derivative drug which acts as a potent and selective 5-HT2C receptor agonist, with an EC50 of 1nM and 15x selectivity over 5-HT2A, although it only has moderate selectivity of 3x over the closely related 5-HT2B receptor. It has thermogenic and anorectic effects in animal studies, making it potentially useful for the treatment of obesity.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|